Send mail to Author

Alirocumab reduces total nonfatal cardiovascular and fatal events: The ODYSSEY OUTCOMES trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
 __   _    _    _    _    _     _____               ______  
| || | || | || | || | \  / ||  |  ___||     ___    /_   _// 
| '--' || | || | || |  \/  ||  | ||__      /   ||   -| ||-  
| .--. || | \\_/ || | .  . ||  | ||__     | [] ||   _| ||_  
|_|| |_||  \____//  |_|\/|_||  |_____||    \__ ||  /_____// 
`-`  `-`    `---`   `-`  `-`   `-----`      -|_||  `-----`  
                                             `-`
 


Back to frontdoor view

OPUS4 Logo